Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Gilbody

Showing results (271-280 of 295) with videos related to

Pageof 30
Sort By:
The Lancet. Healthy Longevity|February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Health Technology Assessment (Winchester, England)|March 2, 2017
CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectivenessHelen Lewis, Joy Adamson, Katie Atherton, et al.
Health Technology Assessment (Winchester, England)|November 25, 2017
CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectivenessKatharine Bosanquet, Joy Adamson, Katie Atherton, et al.
American Journal of Epidemiology|April 19, 2017
Selective Cutoff Reporting in Studies of Diagnostic Test Accuracy: A Comparison of Conventional and Individual-Patient-Data Meta-Analyses of the Patient Health Questionnaire-9 Depression Screening ToolBrooke Levis, Andrea Benedetti, Alexander W Levis, et al.
JAMA Network Open|June 24, 2024
Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized TrialTony Kendrick, Beth Stuart, Hannah Bowers, et al.
Health Technology Assessment (Winchester, England)|September 25, 2019
A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCTEmily Peckham, Catherine Arundel, Della Bailey, et al.
The Lancet. Psychiatry|April 13, 2019
Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trialSimon Gilbody, Emily Peckham, Della Bailey, et al.
The Lancet. Psychiatry|May 14, 2023
Gone Too Soon: priorities for action to prevent premature mortality associated with mental illness and mental distressRory C O'Connor, Carol M Worthman, Marie Abanga, et al.
General Hospital Psychiatry|April 29, 2021
Effectiveness of collaborative care in reducing suicidal ideation: An individual participant data meta-analysisChristos Grigoroglou, Christina van der Feltz-Cornelis, Alexander Hodkinson, et al.
Depression and Anxiety|September 22, 2018
Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4Miyabi Ishihara, Daphna Harel, Brooke Levis, et al.
Pageof 30

Showing results (271-280 of 295) with videos related to

Sort By:
Pageof 30
The Lancet. Healthy Longevity|February 4, 2024
Behavioural activation to mitigate the psychological impacts of COVID-19 restrictions on older people in England and Wales (BASIL+): a pragmatic randomised controlled trialSimon Gilbody, Elizabeth Littlewood, Dean McMillan, et al.
Health Technology Assessment (Winchester, England)|March 2, 2017
CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectivenessHelen Lewis, Joy Adamson, Katie Atherton, et al.
Health Technology Assessment (Winchester, England)|November 25, 2017
CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectivenessKatharine Bosanquet, Joy Adamson, Katie Atherton, et al.
American Journal of Epidemiology|April 19, 2017
Selective Cutoff Reporting in Studies of Diagnostic Test Accuracy: A Comparison of Conventional and Individual-Patient-Data Meta-Analyses of the Patient Health Questionnaire-9 Depression Screening ToolBrooke Levis, Andrea Benedetti, Alexander W Levis, et al.
JAMA Network Open|June 24, 2024
Internet and Telephone Support for Discontinuing Long-Term Antidepressants: The REDUCE Cluster Randomized TrialTony Kendrick, Beth Stuart, Hannah Bowers, et al.
Health Technology Assessment (Winchester, England)|September 25, 2019
A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCTEmily Peckham, Catherine Arundel, Della Bailey, et al.
The Lancet. Psychiatry|April 13, 2019
Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trialSimon Gilbody, Emily Peckham, Della Bailey, et al.
The Lancet. Psychiatry|May 14, 2023
Gone Too Soon: priorities for action to prevent premature mortality associated with mental illness and mental distressRory C O'Connor, Carol M Worthman, Marie Abanga, et al.
General Hospital Psychiatry|April 29, 2021
Effectiveness of collaborative care in reducing suicidal ideation: An individual participant data meta-analysisChristos Grigoroglou, Christina van der Feltz-Cornelis, Alexander Hodkinson, et al.
Depression and Anxiety|September 22, 2018
Shortening self-report mental health symptom measures through optimal test assembly methods: Development and validation of the Patient Health Questionnaire-Depression-4Miyabi Ishihara, Daphna Harel, Brooke Levis, et al.
Pageof 30